Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria, Adit Ben‐Baruch
Cancer Letters (2008) Vol. 267, Iss. 2, pp. 271-285
Closed Access | Times Cited: 555

Showing 1-25 of 555 citing articles:

Eicosanoids and cancer
Dingzhi Wang, Raymond N. DuBois
Nature reviews. Cancer (2010) Vol. 10, Iss. 3, pp. 181-193
Open Access | Times Cited: 1676
Chemotaxis in cancer
Evanthia T. Roussos Torres, John S. Condeelis, Antonia Patsialou
Nature reviews. Cancer (2011) Vol. 11, Iss. 8, pp. 573-587
Open Access | Times Cited: 868
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention
Manuel Picon‐Ruiz, Cynthia Morata‐Tarifa, Janeiro J. Valle‐Goffin, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 5, pp. 378-397
Open Access | Times Cited: 761
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Yiran Liang, Hanwen Zhang, Xiaojin Song, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 14-27
Closed Access | Times Cited: 707
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
Zvi Granot, Erik Henke, Elizabeth Comen, et al.
Cancer Cell (2011) Vol. 20, Iss. 3, pp. 300-314
Open Access | Times Cited: 700
Cancer Immunotherapy by Dendritic Cells
Cornelis J.M. Melief
Immunity (2008) Vol. 29, Iss. 3, pp. 372-383
Open Access | Times Cited: 504
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim, Arseniy E. Yuzhalin, Alex Gordon‐Weeks, et al.
Oncotarget (2016) Vol. 7, Iss. 19, pp. 28697-28710
Open Access | Times Cited: 455
Epithelial stem cells, wound healing and cancer
Esther N. Arwert, Esther Hoste, Fiona M. Watt
Nature reviews. Cancer (2012) Vol. 12, Iss. 3, pp. 170-180
Closed Access | Times Cited: 419
The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci, Alfonso Colombatti
Mediators of Inflammation (2014) Vol. 2014, pp. 1-12
Open Access | Times Cited: 395
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Akihiro Tsuyada, Amy Yin Man Chow, Jun Wu, et al.
Cancer Research (2012) Vol. 72, Iss. 11, pp. 2768-2779
Open Access | Times Cited: 381
The chemokine system in cancer biology and therapy
Alberto Mantovani, Benedetta Savino, Massimo Locati, et al.
Cytokine & Growth Factor Reviews (2009) Vol. 21, Iss. 1, pp. 27-39
Closed Access | Times Cited: 376
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 4, pp. 1361-1369
Open Access | Times Cited: 371
Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
Géraldine Genard, Stéphane Lucas, Carine Michiels
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 368
Key chemokines direct migration of immune cells in solid tumors
Karan Kohli, Venu G. Pillarisetty, Teresa S. Kim
Cancer Gene Therapy (2021) Vol. 29, Iss. 1, pp. 10-21
Open Access | Times Cited: 350
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
Kristina Goetze
International Journal of Oncology (2011)
Open Access | Times Cited: 337
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Scott A. Bergfeld, Yves A. DeClerck
Cancer and Metastasis Reviews (2010) Vol. 29, Iss. 2, pp. 249-261
Closed Access | Times Cited: 331
The CCL5/CCR5 Axis in Cancer Progression
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 302
Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression
Candace A. Gilbert, Joyce M. Slingerland
Annual Review of Medicine (2012) Vol. 64, Iss. 1, pp. 45-57
Closed Access | Times Cited: 290
Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition
Gali Soria, Maya Ofri-Shahak, Ilana Haas, et al.
BMC Cancer (2011) Vol. 11, Iss. 1
Open Access | Times Cited: 260
Anti‐tumour strategies aiming to target tumour‐associated macrophages
Xiaoqiang Tang, Chunfen Mo, Yongsheng Wang, et al.
Immunology (2012) Vol. 138, Iss. 2, pp. 93-104
Open Access | Times Cited: 252
Mechanisms of Regulation of the Chemokine-Receptor Network
Martin J. Stone, Jenni A. Hayward, Cheng Huang, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 2, pp. 342-342
Open Access | Times Cited: 251
CCL2/CCR2 signaling in cancer pathogenesis
Qiongyu Hao, Jaydutt V. Vadgama, Piwen Wang
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 239
The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
Teizo Yoshimura
Cellular and Molecular Immunology (2018) Vol. 15, Iss. 4, pp. 335-345
Open Access | Times Cited: 220
CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
Susanne Svensson, Annelie Abrahamsson, Gabriela Vazquez Rodriguez, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 16, pp. 3794-3805
Open Access | Times Cited: 196
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Xuanmao Jiao, Omar Nawab, Tejal Patel, et al.
Cancer Research (2019) Vol. 79, Iss. 19, pp. 4801-4807
Open Access | Times Cited: 194
Page 1 - Next Page

Scroll to top